Market Place
Sourcing Support
Genflow Secures Non-Dilutive Financial Support
21 Oct 2024 //
ACCESSWIRE
Therapeutic Solutions Gets Patent For Lung Disease Cell Therapy
16 May 2024 //
BUSINESSWIRE
Campbell Neurosciences Appoints Raymond Oliver As Chairman
09 May 2024 //
BUSINESSWIRE
Therapeutic Solutions Granted Patent on Available QuadraMune Nutraceutical
04 Mar 2024 //
BUSINESSWIRE
Therapeutic Solutions Announces Finding Regarding MOA of its JadiCell Product
29 Feb 2024 //
BUSINESSWIRE
Therapeutic Solutions Files Patent on “Facilitating Effects” of JadiCells
26 Feb 2024 //
BUSINESSWIRE
Therapeutic Solutions Files Lawsuit to Obtain Identities of Entities
22 Jan 2024 //
BUSINESSWIRE
Therapeutic Solutions Launches Adult Stem Cell Therapy Company
16 Jan 2024 //
BUSINESSWIRE
Res Nova Announces Positive Data on Cancer Patients Treated with FloraStilbene™
03 Jan 2024 //
BUSINESSWIRE
Therapeutic Solutions International Announces Formation of ALS Biologics Inc
11 Dec 2023 //
BUSINESSWIRE
Therapeutic Solutions & Campbell Publish on Nutritional Modulation of Indolamine
27 Nov 2023 //
BUSINESSWIRE
Therapeutic Solutions Collaborates on Publication on Personalized Immunotherapy
20 Nov 2023 //
BUSINESSWIRE
Therapeutic Solutions Reports Advancement in Stem Cell Therapy
11 Sep 2023 //
BUSINESSWIRE
Campbell Receives Notice of Allowance on Suicide Prevention Drug Candidate
31 Jul 2023 //
BUSINESSWIRE
TSOI Files for Orphan Drug Designation Use of JadiCell Stem Cells Adult Stem Cells
12 Jul 2023 //
BUSINESSWIRE
Therapeutic Solutions Files for ODD Using JadiCell Adult Universal Donor Stem Cells
26 Jun 2023 //
BUSINESSWIRE
Therapeutic Solutions Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel
22 May 2023 //
BUSINESSWIRE
Therapeutic Solutions Spin-Off Res Nova Bio Partners with Cure Stat Rx
15 May 2023 //
BUSINESSWIRE
Therapeutic Solutions Launches VasoSome Vascular Based on Successful Treatment
01 May 2023 //
BUSINESSWIRE
Therapeutic Solutions Spin Off Campbell Creates Test for Suicidal Ideations
20 Mar 2023 //
BUSINESSWIRE
Therapeutic Solutions Advances Chronic Obstructive Pulmonary Disease Program
13 Mar 2023 //
BUSINESSWIRE
Therapeutic Solutions Announces Plans to Initiate Breast Cancer Trial
06 Mar 2023 //
BUSINESSWIRE
Therapeutic Solutions Announces Antigen Blockade of Pathological Immune Response
04 Jan 2023 //
BUSINESSWIRE
Therapeutic Granted Broad Patent on Treatment of Neurodegenerative
28 Nov 2022 //
BUSINESSWIRE
Therapeutic Announces Donor Myeloid Derived Suppressor Therapy Platform
14 Nov 2022 //
BUSINESSWIRE
Therapeutic Solutions Spin-Off Res Nova Bio Collaborates with Veltmeyer MD Inc
07 Nov 2022 //
BUSINESSWIRE
Therapeutic Solutions - Launch of Cancer Immunotherapy Spin-Off Res Nova Bio
27 Oct 2022 //
BUSINESSWIRE
Therapeutic Solutions Announces Successful Treatment of Epilepsy
24 Oct 2022 //
BUSINESSWIRE
Therapeutic Solutions Granted US Patent on Ability of QuadraMune Nutraceutical
10 Oct 2022 //
BUSINESSWIRE
Therapeutic Solutions Secures Financing to Complete PIII Stem Cell Trial
20 Sep 2022 //
BUSINESSWIRE
Campbell Announces Preclinical Studies of CampbellCell for Bipolar Disorder
19 Sep 2022 //
BUSINESSWIRE
Therapeutic Solutions Develops Post JadiCell Maintenance Therapy for COPD
12 Sep 2022 //
BUSINESSWIRE
Therapeutic Solutions International Develops Gene Silencing Therapy for ARDS
29 Aug 2022 //
BUSINESSWIRE
Therapeutic Files with FDA to Expand PIII Trial to Include All Causes of ARDS
25 Aug 2022 //
BUSINESSWIRE
Therapeutic Solutions International Reports Superior Efficacy of ApoptoCyte™
12 Aug 2022 //
BUSINESSWIRE
Therapeutic Soln. Granted Emergency IND for Expanded Patient Access to JadiCell
18 Jul 2022 //
BUSINESSWIRE
Therapeutic Solutions Recruits Dr. Donald Banerji to Scientific Advisory Board
25 May 2022 //
BUSINESSWIRE
Therapeutic Solutions Receives IND Number 28508 for COPD Trial
23 May 2022 //
BUSINESSWIRE
Therapeutic Solutions Files Patent on Leukine-Induced MDS Cells and JadiCell
12 May 2022 //
BUSINESSWIRE
Therapeutic Solutions International Files Investigational NDA for COPD
09 May 2022 //
BUSINESSWIRE
Therapeutic Solutions Launches PIII Trial for Treating COVID-19 Lung Damage
02 May 2022 //
BUSINESSWIRE
Therapeutic Solutions Identifies Novel Biological Pathway Used by PIII JadiCell
19 Apr 2022 //
BUSINESSWIRE
Therapeutic Solutions International Provides Correction Re Prior Release
30 Mar 2022 //
BUSINESSWIRE
Biorasi to Initiate and Run Phase III FDA Registration Trial for JadiCell
28 Mar 2022 //
BUSINESSWIRE
Therapeutic Solutions Completes Purchase of FDA Phase III JadiCell Stem Cell IND
25 Mar 2022 //
BUSINESSWIRE
Campbell Neurosciences Announces Positive Preclinical Data Using CampbellCell
14 Feb 2022 //
BUSINESSWIRE
Therapeutic Solutions International Successfully Treats “No Option” Patients
30 Dec 2021 //
BUSINESSWIRE
Therapeutic Solutions International Utilizes Mesenchymal Stem Cell Exosomes
04 Oct 2021 //
PRNEWSWIRE
Therapeutic approaches for the treatment of hepatocellular carcinoma
30 Sep 2021 //
BIOSPECTRUMASIA
Therapeutic Solutions Files Patent on Novel Cellular Therapy Combination
22 Sep 2021 //
PRNEWSWIRE
Therapeutic Solutions Files New Drug Application with FDA for Cancer
30 Aug 2021 //
PRNEWSWIRE
Therapeutic Solutions Recruits Stem Cell Pioneer F. Silva to Advisory Board
26 Aug 2021 //
PRNEWSWIRE
Therapeutic Solutions posts new data from JadiCells COPD animal study
23 Aug 2021 //
SEEKINGALPFA
Therapeutic Solutions International Prepares to Apply for EUA for JadiCell™
16 Aug 2021 //
PR NEWSWIRE
Therapeutic Solutions International Optimizes Targeting the "Achilles Heel"
24 May 2021 //
PRNEWSWIRE
Therapeutic Solutions International Develops Novel Stem Cell Based Therapy
21 May 2021 //
PRNEWSWIRE
Therapeutic Solutions International Comes to Agreement with FDA
30 Apr 2021 //
PRNEWSWIRE
Therapeutic Solutions International Reports Regression of Established Tumors
26 Apr 2021 //
PRNEWSWIRE
Therapeutic Solutions Spin-Off Campbell Neurosciences Identifies moa
19 Apr 2021 //
PRNEWSWIRE
Therapeutic Solutions International Demonstrates Potent Selective Destruction
29 Mar 2021 //
PRNEWSWIRE
